CSL Limited
-5.8%

Healthcare & biotech / Biotechnology

🚀 Founded 1916 🌎 Australia 🏷️ CSLLY AU000000CSL8 ⭐ 1000 DCF 44.02 💰67.84

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (3) 🏢 Company Q&A (465) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

🔥 Video Insights

[Disclaimer]

CSL Limited: Why the Stock is Low and What Investors Should Know

September 18, 2025

Explore why CSL Limited’s stock is trading low, covering recent financials, product portfolio, dividends, risks, and potential growth. Learn the most relevant insights today for investors considering this global biotechnology leader.

Why CSL Limited Stock is Down - Could This Be a Hidden Opportunity?

August 19, 2025

In this video, we review CSL Limited, a leading biotechnology company, exploring why its stock is down, its financial health, recent developments, dividends, and long-term prospects. This analysis is for educational purposes only and helps investors understand the key factors affecting CSL Limited and whether it might be a hidden opportunity.

CSL Stock Is Down — Is This Biotech Titan Finally Undervalued?

June 16, 2025

CSL Limited is a global biotech leader with a strong pipeline, consistent dividends, and a historically low valuation. But with recent acquisition challenges and rising costs, is now the time to invest? We break down the current numbers, risks, and opportunities in this fast-moving analysis. More insights at InsightfulValue.com.

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.